0
0
11/11/22 at 3:55pm
Organization
Cancertherapyadvisor.com
Author
Erin Clancy
38 words
0
Comments
Two new studies shed light on the complexity of preventing subsequent breast cancer events in patients with ductal carcinoma in situ.
You are the first to view
https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/dcis-endocrine-therapy-duration-tied-benefit-young-patients-reject-et/
Create an account
or login to join the discussion